Vincent Soriano
Researcher Next ID · RN-035144
Researcher · Immunology and Microbiology
Fundación Instituto Valenciano de Oncología
Valencia, Spain
- Works count
- 1,174
- Citation count
- 36,381
- H-index
- 91
- i10-index
- 633
Research interests
Publications
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis
Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab100
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.034
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
PLoS Medicine · 2015 · 10.1371/journal.pmed.1001810
Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
New England Journal of Medicine · 2013 · 10.1056/nejmoa1213557
Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
The Journal of Infectious Diseases · 2012 · https://doi.org/10.1093/infdis/jis750
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Nature Genetics · 2011 · 10.1038/ng.926
European guidelines on the clinical management of HIV-1 tropism testing
The Lancet Infectious Diseases · 2011 · https://doi.org/10.1016/s1473-3099(10)70319-4
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
Journal of Viral Hepatitis · 2011 · 10.1111/j.1365-2893.2011.01499.x
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
The Lancet · 2010 · 10.1016/s0140-6736(10)60829-x
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
AIDS · 2009 · https://doi.org/10.1097/qad.0b013e3283262a64
Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study
Clinical Infectious Diseases · 2009 · 10.1086/598507
New common variants affecting susceptibility to basal cell carcinoma
Nature Genetics · 2009 · https://doi.org/10.1038/ng.412
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma
Nature Genetics · 2008 · 10.1038/ng.161
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults
HIV Medicine · 2008 · 10.1111/j.1468-1293.2007.00535.x
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
AIDS · 2007 · 10.1097/qad.0b013e3281084e4d
Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy
The Journal of Infectious Diseases · 2005 · https://doi.org/10.1086/432762
Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
The Journal of Infectious Diseases · 2005 · https://doi.org/10.1086/432916
Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration
PLoS Medicine · 2005 · https://doi.org/10.1371/journal.pmed.0020112
Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir
Antiviral Therapy · 2005 · 10.1177/135965350501000612
Hepatocellular carcinoma in HIV-infected patients
AIDS · 2004 · 10.1097/00002030-200411190-00009
Care of patients with hepatitis C and HIV co-infection
AIDS · 2004 · 10.1097/00002030-200401020-00001
Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study
Clinical Infectious Diseases · 2003 · 10.1086/380130
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
AIDS · 2002 · https://doi.org/10.1097/00002030-200204120-00001
Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 10.1097/00126334-200108150-00002
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
AIDS · 1998 · 10.1097/00002030-199809000-00008
Current projects
No projects listed.